Method for assisting determination on suitability of esophageal cancer for endoscopic therapy, method for determining suitability of esophageal cancer for endoscopic therapy, method for collecting data for use in determination on suitability of esophageal cancer for endoscopic therapy, method for diagnosing suitability of esophageal cancer for endoscopic therapy, in vitro method for assisting determination on suitability of esophageal cancer for endoscopic therapy, ...

A method for determining suitability of esophageal cancer for endoscopic therapy, the method comprising:

• measuring an expression level of at least one or more selected from the group consisting of CXCL2 and VEGFA in a sample collected from a subject, and comparing the expression level with a reference value.

A method for collecting data for use in determination on suitability of esophageal cancer for endoscopic therapy, the method comprising:

• measuring an expression level of at least one or more selected from the group consisting of CXCL2 and VEGFA in a sample collected from a subject, and comparing the expression level with a reference value.

A method for diagnosing suitability of esophageal cancer for endoscopic therapy, the method comprising:

• measuring an expression level of at least one or more selected from the group consisting of CXCL2 and VEGFA in a sample collected from a subject, and comparing the expression level with a reference value.

A method for testing on suitability of esophageal cancer for endoscopic therapy, the method comprising:

• measuring an expression level of at least one or more selected from the group consisting of CXCL2 and VEGFA in a sample collected from a subject, and comparing the expression level with a reference value.

An in vitro method for assisting determination on suitability of esophageal cancer for endoscopic therapy, the method comprising:

• measuring an expression level of at least one or more selected from the group consisting of CXCL2 and VEGFA in a sample collected from a subject, and comparing the expression level with a reference value.

A method for diagnosing suitability of esophageal cancer for endoscopic therapy, the method comprising:

• measuring an expression level of at least one or more selected from the group consisting of CXCL2 and VEGFA in a sample collected from a subject, and comparing the expression level with a reference value.

A diagnostic kit that is used to determine suitability of esophageal cancer for endoscopic therapy, the diagnostic kit comprising:

• a reagent kit that is used for measuring at least one or more selected from the group consisting of an expression level of CXCL2 in a sample and an expression level of VEGFA in a sample.